Related Experiment Video
Updated: Aug 17, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
Rasmussen's syndrome: intractable epilepsy and progressive neurological deterioration from a unilateral central
1Department of Pediatrics, Division of Pediatric Neurology, University of Florida Health Science Center, Gainesville, FL 32610, USA. Carnepr@peds.ufl.edu
Abstract:
Rasmussen's syndrome (chronic encephalitis with epilepsy) is a rare neurological disorder of unknown cause characterized by severe epilepsy, hemiplegia, dementia, and inflammation of the brain, and progressive functional and structural destruction of a single cerebral hemisphere. While one mechanism underlying the pathogenesis of Rasmussen's encephalitis has been hypothesized to be mediated by production of excitotoxic GluR3 autoantibodies to the a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor, other neuropathological etiologies have also been indicated. Proposed therapies have included antiepileptics, steroids, antiviral agents, alpha-interferon, and immunoglobulin. The mainstay of therapy is surgical hemispherectomy. To date, no medical therapies have permanently halted neurologic deterioration.
Related Concept Videos
Multiple Sclerosis l: Introduction
Rocky Mountain Spotted Fever
Hepatic Encephalopathy
Seizures l: Introduction
Encephalitis ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology
